...
首页> 外文期刊>Chinese Medical Journal >Misoprostol in labour induction of term pregnancy: a meta-analysis
【24h】

Misoprostol in labour induction of term pregnancy: a meta-analysis

机译:米索前列醇在引产足月妊娠中的荟萃分析

获取原文
获取原文并翻译 | 示例

摘要

Objective To evaluate the efficacy and safety of misoprostol in term labour induction. Data sources Data from published English and Chinese literatures about misoprostol in term labour induction were identified from Medline and CBMdisk ( using the search terms " misoprostol" and " labour induction") before 2001; hand searches of reference lists of original studies and reviews (including meta-analyses) and contact with investigators in this field before 2001. Study selection Studies were included if they had data on misoprostol and labour induction. Altogether 623 articles were found and 124 were admitted, including 19 287 cases. Data extraction Data were collected on efficacy and incidence of side-effects of misoprostol and oxytocin. Data were checked for consistency within the published articles and converted into a standard format for incorporation into a central database. Data synthesis The average successful induction rate, rates of caesarean section; incidence of tachysystole, hypertonus of uterus and precipitous labour, and rates of meconium stained amniotic fluid between the misoprostol and oxytocin groups were significantly different (P<0.05). There were no significant differences between the two groups concerning the average interval from the administration of misoprostol and oxytocin to the onset of labour, duration of the total stage of labour, incidence rate of foetal distress, neonatal asphyxia (1 -minute Apgar score ≤ 7), postpartum haemorrhage or amount of blood loss in postpartum. Conclusions Misoprostol is a superior agent over oxytocin on the induction of term labour, but its application might increase the risk of precipitatous labour, abnormal uterine contractions or meconium stained amniotic fluid. Therefore, the doasges and regimens of the agent need further investigation.
机译:目的评估米索前列醇在足月引产中的疗效和安全性。数据来源在2001年之前,从Medline和CBMdisk(使用搜索词“ misoprostol”和“分娩诱导”)中,从已发表的中,英文文献中有关米索前列醇在术语引产方面的数据进行了鉴定;手工搜索原始研究和综述的参考文献清单(包括荟萃分析),并在2001年前与该领域的研究人员联系。研究选择如果包括米索前列醇和引产的数据,则包括在内。共找到623篇文章,入院124篇,其中19 287例。数据提取收集有关米索前列醇和催产素的功效和副作用发生率的数据。在发布的文章中检查数据的一致性,并将其转换为标准格式以并入中央数据库。数据综合平均成功诱导率,剖宫产率;米索前列醇和催产素组之间的心动过速,子宫和子宫过度紧张的发生率以及胎粪污染的羊水比例明显不同(P <0.05)。两组之间从米索前列醇和催产素给药到分娩开始的平均间隔,分娩总阶段的持续时间,胎儿窘迫的发生率,新生儿窒息(1分钟Apgar评分≤7)没有显着差异。 ),产后出血或产后失血量。结论米索前列醇在催产中比催产素优越,但其应用可能会增加宫缩性宫缩,子宫收缩异常或胎粪污染羊水的风险。因此,该剂的剂量和治疗方案需要进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号